Tight Blood Sugar Control Boosts Heart Stem Cells After Heart Attack

This completed clinical trial investigated whether tight glycemic control could enhance the heart's natural regenerative capacity following acute myocardial infarction. The study addressed a critical gap in understanding how blood sugar management affects cardiac stem cell activity during heart attack recovery.

Researchers enrolled 65 patients experiencing their first heart attack who required coronary bypass surgery. The study design included 25 normoglycemic patients as controls, while 40 hyperglycemic patients were randomized into two groups: intensive glycemic control targeting 80-140 mg/dl or conventional control targeting 180-200 mg/dl. Treatment lasted three days before surgery using insulin infusion followed by subcutaneous insulin.

The team measured multiple cardiac health markers including echocardiographic parameters, oxidative stress indicators, cell death markers, and most importantly, cardiac stem cells in tissue samples from the peri-infarcted area. They specifically analyzed c-kit, MDR1, and Sca-1 positive cells, which represent different populations of cardiac stem cells crucial for heart repair.

While the trial's completion status indicates data collection finished, the specific results regarding stem cell enhancement aren't detailed in this summary. However, the study's design suggests important implications for post-heart attack care protocols. If tight glycemic control indeed increases cardiac stem cells, this could revolutionize recovery strategies and potentially improve long-term heart function outcomes. This research contributes valuable insights into the intersection of metabolic health and cardiovascular regeneration, offering potential pathways for optimizing heart attack recovery through precise blood sugar management.